S

Swiss Life AG

2583 employees

Swiss Life Private Equity Partners specializes in asset management and investment consulting in the private equity sector.

Investor insights

Sectors invested in

Pharmaceutical2

Biotechnology2

Small molecules1

Health Care1

Virology and Liver Disease1

Biopharma1

Cancer therapeutics1

Drug discovery1

Nuclear receptors1

Liver Diseases1

NASH1

Drug development1

Funding rounds participated in

$8.3M sweet spot round size

Most of their 5 investments are in rounds between $7.6M and $12M

Investor type

Private Equity Firm

Basic info

Industry

financial services

Sectors

Lebensversicherung

Pensionskasse

Hypotheken

Finanzplanung

Krankenversicherung (nur in Frankreich)

Unfall u.a.)

Asset Management

Berufliche Vorsorge

Sozialversicherung (Taggeld

Immobilien

Date founded

1857

Investments made

U

Undisclosed raised $1.5B on August 30, 2022

Investors: Ardian, Northleaf Capital Partners and Swiss Life AG

P

Phenex Pharmaceuticals AG raised $7.9M on September 21, 2010

Investors: EVP Capital Management AG, KfW, LBBW Venture Capital GmbH, Creathor Ventures and Swiss Life AG

E

Enanta Pharmaceuticals raised $12M on January 14, 2004

Investors: Techno Venture Management, BioVentures Investors, Yasuda Enteprise Development Co. Ltd, Advent International and Swiss Life AG

U

Undisclosed raised $7.6M on April 25, 2002

Investors: INDUSTRIAL CHEMICAL AND PAINTS, Bowman Capital, Kleiner Perkins and Swiss Life AG

U

Undisclosed raised $8.3M on February 27, 2001

Investors: Techno Venture Management and Swiss Life AG